• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 C-TIRADS 分析的甲状腺乳头状癌中央区淋巴结转移的相关因素。

Factors of Central Lymph Node Metastasis in Papillary Thyroid Cancer Based on C-TIRADS Analysis.

机构信息

Department of Ultrasound, First People's Hospital of Foshan, Foshan, China.

Zhuhai Campus, Zunyi Medical University, Zunyi, China.

出版信息

Horm Metab Res. 2023 Sep;55(9):585-591. doi: 10.1055/a-2142-4811. Epub 2023 Jul 27.

DOI:10.1055/a-2142-4811
PMID:37500084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10484640/
Abstract

To study risk factors for central lymph node metastasis (CLNM) in papillary thyroid cancer (PTC) using the Chinese Thyroid Imaging Reporting and Data System (C-TIRADS). We retrospectively analysed patients who underwent PTC surgery and central lymph node dissection at First People's Hospital of Foshan City. The clinical and ultrasonic data of the patients from 1150 cases were analysed by multivariate regression to evaluate the correlation between grayscale ultrasound (US) features, C-TIRADS score, and the classification of thyroid nodules and CLNM of PTCs. The C-TIRADS score was 3.0±1.0 in the CLNM group, which was higher than that in the non-CLNM group (p<0.001). Sex (male) (OR=1.586, 95% CI 1.232-2.042, p<0.001), age (≤45 years) (OR=1.508, 95% CI 1.184-1.919, p=0.001), location of nodes (lower pole) (OR=2.193, 95% CI 1.519-3.166, p<0.001), number (multifocal) (OR=2.204, 95% CI 1.227-2.378, p<0.001), microcalcification (OR=1.610, 95% CI 2.225-4.434, p=0.002), extrathyroidal extension (OR=2.204, 95% CI 1.941-3.843, p<0.001), maximum diameter of nodule (≥20 mm) (OR=3.211, 95% CI 2.337-4.411, p<0.001), and C-TIRADS score (OR=1.356, 95% CI 1.204-1.527, p<0.001) were PTC in independent risk factors for CLNM. The C-TIRADS score of PTC combined with the location, number, size, and ultrasound features of the lesion and the patient's sex and age are important in predicting whether they present with CLNM and provide a reference basis for the clinical formulation of a reasonable surgical treatment plan.

摘要

利用中国甲状腺影像报告和数据系统(C-TIRADS)研究甲状腺乳头状癌(PTC)中央淋巴结转移(CLNM)的危险因素。我们回顾性分析了在佛山市第一人民医院接受 PTC 手术和中央淋巴结清扫术的患者。通过多元回归分析 1150 例患者的临床和超声数据,评估灰阶超声(US)特征、C-TIRADS 评分、甲状腺结节分类与 PTC 中央淋巴结转移的相关性。CLNM 组的 C-TIRADS 评分为 3.0±1.0,高于非 CLNM 组(p<0.001)。性别(男性)(OR=1.586,95%CI 1.232-2.042,p<0.001)、年龄(≤45 岁)(OR=1.508,95%CI 1.184-1.919,p=0.001)、淋巴结位置(下极)(OR=2.193,95%CI 1.519-3.166,p<0.001)、数量(多灶性)(OR=2.204,95%CI 1.227-2.378,p<0.001)、微钙化(OR=1.610,95%CI 2.225-4.434,p=0.002)、甲状腺外侵犯(OR=2.204,95%CI 1.941-3.843,p<0.001)、结节最大直径(≥20mm)(OR=3.211,95%CI 2.337-4.411,p<0.001)和 C-TIRADS 评分(OR=1.356,95%CI 1.204-1.527,p<0.001)是 PTC 发生 CLNM 的独立危险因素。PTC 的 C-TIRADS 评分结合病变的位置、数量、大小和超声特征以及患者的性别和年龄,对预测 CLNM 具有重要意义,并为临床制定合理的手术治疗方案提供参考依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e5/10484640/f24fba6c865a/10-1055-a-2142-4811-i2023-03-0074-0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e5/10484640/f24fba6c865a/10-1055-a-2142-4811-i2023-03-0074-0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e5/10484640/f24fba6c865a/10-1055-a-2142-4811-i2023-03-0074-0001.jpg

相似文献

1
Factors of Central Lymph Node Metastasis in Papillary Thyroid Cancer Based on C-TIRADS Analysis.基于 C-TIRADS 分析的甲状腺乳头状癌中央区淋巴结转移的相关因素。
Horm Metab Res. 2023 Sep;55(9):585-591. doi: 10.1055/a-2142-4811. Epub 2023 Jul 27.
2
Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.临床研究:甲状腺乳头状癌中央区淋巴结转移的超声危险因素。
Front Endocrinol (Lausanne). 2021 Nov 30;12:791970. doi: 10.3389/fendo.2021.791970. eCollection 2021.
3
High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma(cT1N0).单侧乳头状甲状腺癌(cT1N0)对侧中央区淋巴结转移的高危因素。
Eur J Surg Oncol. 2021 Apr;47(4):882-887. doi: 10.1016/j.ejso.2020.10.018. Epub 2020 Oct 18.
4
Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.分析预测甲状腺乳头状癌颈淋巴结转移的风险因素:966 例患者研究。
BMC Cancer. 2019 Jun 25;19(1):622. doi: 10.1186/s12885-019-5835-6.
5
Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.预测甲状腺乳头状癌中央区淋巴结和侧颈区淋巴结转移的因素。
Clin Transl Oncol. 2019 Nov;21(11):1482-1491. doi: 10.1007/s12094-019-02076-0. Epub 2019 Mar 16.
6
Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.甲状腺乳头状癌中央区淋巴结转移的危险因素:3273例单中心回顾性分析
Medicine (Baltimore). 2017 Oct;96(43):e8365. doi: 10.1097/MD.0000000000008365.
7
Ultrasound Elastic Parameters Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.超声弹性参数预测甲状腺乳头状癌中央区淋巴结转移。
J Surg Res. 2020 Sep;253:69-78. doi: 10.1016/j.jss.2020.03.042. Epub 2020 Apr 23.
8
Predictive Factors of Central-Compartment Lymph Node Metastasis for Clinical N0 Papillary Thyroid Carcinoma With Strap Muscle Invasion.伴有带状肌侵犯的临床N0期乳头状甲状腺癌中央区淋巴结转移的预测因素
Front Endocrinol (Lausanne). 2020 Sep 8;11:511. doi: 10.3389/fendo.2020.00511. eCollection 2020.
9
Ultrasonic Feature Prediction of Large-Number Central Lymph Node Metastasis in Clinically Node-Negative Solitary Papillary Thyroid Carcinoma.临床隐匿性单发乳头状甲状腺癌中大量中央区淋巴结转移的超声特征预测。
Endocr Res. 2023 Oct 2;48(4):112-119. doi: 10.1080/07435800.2023.2249090. Epub 2023 Aug 22.
10
Integrating BRAF mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma.整合 BRAF 突变、超声及临床病理特征预测甲状腺乳头状癌中央区淋巴结转移风险
BMC Cancer. 2022 Apr 27;22(1):461. doi: 10.1186/s12885-022-09550-z.

引用本文的文献

1
Development and validation of a machine learning model for central compartmental lymph node metastasis in solitary papillary thyroid microcarcinoma via ultrasound imaging features and clinical parameters.基于超声成像特征和临床参数的孤立性甲状腺微小乳头状癌中央区淋巴结转移机器学习模型的开发与验证
BMC Med Imaging. 2025 Jul 1;25(1):228. doi: 10.1186/s12880-025-01757-3.

本文引用的文献

1
Clinical significance of extrathyroidal extension to major vessels in papillary thyroid carcinoma.甲状腺乳头状癌中甲状腺外侵犯至大血管的临床意义。
J Endocrinol Invest. 2023 Jun;46(6):1155-1167. doi: 10.1007/s40618-022-01966-5. Epub 2022 Nov 24.
2
Risk factors and prediction models of lymph node metastasis in papillary thyroid carcinoma based on clinical and imaging characteristics.基于临床和影像特征的甲状腺乳头状癌淋巴结转移的危险因素及预测模型
Postgrad Med. 2023 Mar;135(2):121-127. doi: 10.1080/00325481.2022.2135840. Epub 2022 Oct 18.
3
A multi-institutional study of association of sonographic characteristics with cervical lymph node metastasis in unifocal papillary thyroid carcinoma.
一项多机构研究探讨了单发甲状腺乳头状癌的超声特征与颈部淋巴结转移之间的关系。
Front Endocrinol (Lausanne). 2022 Sep 23;13:965241. doi: 10.3389/fendo.2022.965241. eCollection 2022.
4
A Clinical Predictive Model of Central Lymph Node Metastases in Papillary Thyroid Carcinoma.甲状腺乳头状癌中央区淋巴结转移的临床预测模型。
Front Endocrinol (Lausanne). 2022 Jun 16;13:856278. doi: 10.3389/fendo.2022.856278. eCollection 2022.
5
Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.分析 cT1N0 期甲状腺乳头状癌中央区淋巴结转移的相关危险因素。
Front Endocrinol (Lausanne). 2022 Jun 3;13:880911. doi: 10.3389/fendo.2022.880911. eCollection 2022.
6
Using ultrasonographic features to predict the outcomes of patients with small papillary thyroid carcinomas: a retrospective study implementing the 2015 ATA patterns and ACR TI-RADS categories.利用超声特征预测微小乳头状甲状腺癌患者的预后:一项采用2015年美国甲状腺协会(ATA)分型和美国放射学会(ACR)甲状腺影像报告和数据系统(TI-RADS)分类的回顾性研究
Ultrasonography. 2022 Apr;41(2):298-306. doi: 10.14366/usg.21097. Epub 2021 Aug 12.
7
Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.预测临床淋巴结阴性的孤立峡部经典型乳头状甲状腺癌患者对侧和同侧中央淋巴结转移的列线图。
Surgery. 2021 Dec;170(6):1670-1679. doi: 10.1016/j.surg.2021.06.027. Epub 2021 Jul 16.
8
Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.肿瘤浸润 B 细胞在甲状腺乳头状癌淋巴结转移中的诊断和预后价值。
Virchows Arch. 2021 Nov;479(5):947-959. doi: 10.1007/s00428-021-03137-y. Epub 2021 Jun 19.
9
Analyze and compare the predictors of ipsilateral central lymph node metastasis in papillary thyroid carcinoma with cT1a and cT1b stage.分析并比较 cT1a 和 cT1b 期甲状腺乳头状癌同侧中央区淋巴结转移的预测因素。
Asian J Surg. 2021 Nov;44(11):1357-1362. doi: 10.1016/j.asjsur.2021.02.008. Epub 2021 Mar 11.
10
High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma(cT1N0).单侧乳头状甲状腺癌(cT1N0)对侧中央区淋巴结转移的高危因素。
Eur J Surg Oncol. 2021 Apr;47(4):882-887. doi: 10.1016/j.ejso.2020.10.018. Epub 2020 Oct 18.